Literature DB >> 31117085

Association between Growth Differentiation Factor 15 and Non-Dipping Circadian Pattern in Patients with Newly Diagnosed Essential Hypertension.

Erdoğan Sökmen1, Cahit Uçar2, Serkan Sivri3, Mustafa Çelik3, Yalçın Boduroğlu3, Murat Erer3, Alp Yıldırım3, Bilal İlanbey4.   

Abstract

OBJECTIVE: Non-dipper hypertension (HT) confers greater risk compared with dipper HT. Growth differentiation factor 15 (GDF-15) recently emerged as a novel and independent marker of cardiovascular disease, both in diagnostic and prognostic scopes. Our aim was to evaluate the relationship of circadian blood pressure (BP) pattern with serum GDF-15 level in newly diagnosed HT patients without left ventricular hypertrophy. SUBJECTS AND METHODS: Newly diagnosed non-dipper (n = 66) and dipper (n = 60) HT patients were selected according to 24-h ambulatory BP monitoring (ABPM). The controls comprised healthy normotensive subjects (n = 31). Data was collected through physical examination, laboratory analysis, ABPM, and echocardiography. GDF-15 was measured using ELISA.
RESULTS: Greater GDF-15 level was found in the non-dippers compared with the dippers and the controls (557.53 ± 91.7, 513.79 ± 62.86, and 494.44 ± 79.30 ng/L, respectively, p < 0.001). In bivariate linear correlation analysis, GDF-15 correlated positively with glomerular filtration rate (r = 0.180, p =0.030), total cholesterol (r = 0.170, p = 0.038), septal E/E' ratio (r = 0.344, p = 0.001), lateral E/E' ratio (r = 0.366, p < 0.001), nighttime systolic BP (r = 0.166, p = 0.046), and nighttime diastolic BP (r = 0.188, p = 0.024); however, it correlated negatively with septal and lateral E' velocities (r = 0.268, p = 0.005 and r = 0.236, p = 0.013, respectively). Furthermore, GDF-15 level and nighttime diastolic BP remained independently associated with non-dipper HT. In ROC analysis, optimal cutoff value for GDF-15 was 524.6 ng/L with 56.7% sensitivity and 72.4% specificity (AUC: 0.676, 95% CI: 0.580-0.772, p < 0.05).
CONCLUSION: Our results showed GDF-15 upregulation in the non-dipper HT group. GDF-15 and nighttime diastolic BP were independently associated with the non-dipping pattern. This study may suggest possible utilization of GDF-15 in the prediction of non-dipper HT.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Circadian pattern; Dipping hypertension; GDF-15; Non-dipper hypertension

Mesh:

Substances:

Year:  2019        PMID: 31117085      PMCID: PMC6944892          DOI: 10.1159/000501096

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  27 in total

1.  Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography.

Authors:  Miguel A Quiñones; Catherine M Otto; Marcus Stoddard; Alan Waggoner; William A Zoghbi
Journal:  J Am Soc Echocardiogr       Date:  2002-02       Impact factor: 5.251

Review 2.  Ambulatory blood pressure monitoring: from old concepts to novel insights.

Authors:  Mehmet Kanbay; Kultigin Turkmen; Tevfik Ecder; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-07-06       Impact factor: 2.370

3.  Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Levent Cem Mutlu; Nejat Altintas; Murat Aydin; Feti Tulubas; Mustafa Oran; Volkan Kucukyalin; Gizem Kaplan; Ahmet Gurel
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

4.  Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.

Authors:  Lars Wallentin; Ziad Hijazi; Ulrika Andersson; John H Alexander; Raffaele De Caterina; Michael Hanna; John D Horowitz; Elaine M Hylek; Renato D Lopes; Signild Asberg; Christopher B Granger; Agneta Siegbahn
Journal:  Circulation       Date:  2014-10-07       Impact factor: 29.690

5.  Growth differentiation factor (GDF)-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation.

Authors:  Xin-ye Xu; Ying Nie; Fang-fang Wang; Yan Bai; Zhi-zhen Lv; You-yi Zhang; Zi-jian Li; Wei Gao
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

6.  Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts.

Authors:  Shinsuke Hanatani; Yasuhiro Izumiya; Seiji Takashio; Sunao Kojima; Megumi Yamamuro; Satoshi Araki; Taku Rokutanda; Kenichi Tsujita; Eiichiro Yamamoto; Tomoko Tanaka; Shinji Tayama; Koichi Kaikita; Seiji Hokimoto; Seigo Sugiyama; Hisao Ogawa
Journal:  Heart Vessels       Date:  2013-03-23       Impact factor: 2.037

Review 7.  GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective.

Authors:  Ramu Adela; Sanjay K Banerjee
Journal:  J Diabetes Res       Date:  2015-07-27       Impact factor: 4.011

8.  Assessment of left ventricular function and peripheral vascular arterial stiffness in patients with dipper and non-dipper hypertension.

Authors:  Yan Chen; Ju-Hua Liu; Zhe Zhen; Yuan Zuo; Qingshan Lin; Mingya Liu; Chunting Zhao; Min Wu; Gaozhen Cao; Run Wang; Hung-Fat Tse; Kai-Hang Yiu
Journal:  J Investig Med       Date:  2017-09-20       Impact factor: 2.895

9.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

10.  The association of growth differentiation factor-15 with left ventricular hypertrophy in hypertensive patients.

Authors:  Hao Xue; Zhenhong Fu; Yundai Chen; Youhong Xing; Jie Liu; Hang Zhu; Xiao Zhou
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.